World Hemophilia Day: Kedrion’s commitment
Apr 13, 2022 |
CORPORATE
Guaranteeing equitable access to treatment is the central theme of the 2022 edition
Kedrion-Pharmacosmos partnership for the treatment of Anemia in Italy
Mar 03, 2022 |
CORPORATE
Exclusive agreement signed for the distribution of a novel iron-based therapy
Val Romberg completes his assignement as Kedrion’s CEO
Jan 31, 2022 |
CORPORATE
Kedrion and LFB sign industrial cooperation agreement
Jan 31, 2022 |
CORPORATE
Scope is supplying Immunoglobulins to meet patient demand in France
Kedrion in Turkey: ever closer to patients
Jan 18, 2022 |
EVENTS
In 2021, the company committed to strengthening its presence in the country
Kedrion grows in North America as it completes acquisition of Prometic
Oct 18, 2021 |
CORPORATE
Launch is planned for the first ever FDA-approved treatment for patients suffering from Congenital Plasminogen Deficiency
Kedrion Biopharma expands its commitment in Turkey
Oct 14, 2021 |
CORPORATE
Expansion plans revealed at Embassy reception in Ankara on October 14
4ID – Kedrion proud to support new App for patients with Immunodeficiencies
Oct 04, 2021 |
CORPORATE
Our company restates its long-standing and consistent collaboration with IPOPI
Kedrion supports Italian liver transplantology
Sep 29, 2021 |
EVENTS
The company supported the Italian National Continuing Medical Education Program (ECM) event organized by Epateam aimed at specialists in the field
